The Equal Employment Opportunity Commission has sharply pivoted its enforcement priorities, training its sights on corporate diversity, equity, and inclusion (DEI) programs, which—in the agency’s view—embed unlawful race- or sex-based preferences in hiring and promotion. For employers, the message is clear: now is the time to reassess such programs.

If it hasn’t already, the 21st Century ROAD to Housing Act may change how you think about acquisitions, development sites, public land, affordable housing capital, and single-family rental strategy.

Strong LOIs create faster transactions and, even if an attorney is involved, are considerably less expensive than salvaging a weak LOI or proceeding directly to a purchase agreement.

The 2026 ALTA/NSPS Land Title Survey standards took effect on February 23, 2026. The new standards give real estate owners, developers, and lenders opportunities to leverage 2026 ALTA surveys as a more effective risk-management tool.

When buying commercial property in Chicago, or elsewhere in Illinois, many investors ask whether a Phase I Environmental Site Assessment (Phase I) is required. Often times, yes, a Phase I is required.

Illinois employers using E-Verify must follow new notice and procedural requirements when they receive a “no-match” or similar written notification.

For decades, taxpayers and legal professionals have relied on the "mailbox rule": if a document is dropped in a USPS collection box by the deadline, it is considered timely filed. This is no longer a safe assumption.

First-time multifamily buyers in Chicago often focus on price, neighborhood and cap rate but miss legal and compliance issues that silently add cost, delay closing or create post-closing liability.

As 2026 dawns, it is natural to consider the outlook for construction in the coming year.

The Departments issued the FAQs in response to a February 2025 Presidential Executive Order (EO 14216), which directs the Assistant to the President for the Domestic Policy Council to submit policy recommendations to protect access to in vitro fertilization (IVF) and aggressively reduce out-of-pocket and health plan costs for IVF treatment.